Quarterly report pursuant to Section 13 or 15(d)

Share-based Compensation (Tables)

v3.21.2
Share-based Compensation (Tables)
9 Months Ended
Sep. 30, 2021
Share-based Compensation  
Schedule of information about 2019 plan

​

​

​

​

​

​

​

​

​

    

Awards

    

​

    

Awards 

​

​

Reserved for

​

​

​

Available for

​

​

Issuance

​

Awards Issued

​

Grant

2019 Plan

 

20,000,000

 

16,722,616

 

3,277,384

Schedule of incentive stock option activity

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted

​

Weighted

​

​

​

​

Average

​

Average

​

​

Number of

​

Exercise

​

Contractual

​

    

Options

    

 Price

    

Term in Years

Outstanding at January 1, 2020

 

1,000,000

 

$

0.053525

 

9.6

Granted

 

12,705,949

​

$

0.0291

 

10.0

Exercised

 

—

​

 

—

 

—

Forfeited

 

—

​

 

—

 

—

Cancelled

 

—

​

 

—

 

—

Expired

 

—

​

 

—

 

—

Outstanding at December 31, 2020

​

13,705,949

​

$

0.027736

​

9.32

​

​

​

​

​

​

​

​

Granted

​

3,166,667

​

$

0.113158

​

10.0

Exercised

​

—

​

​

—

​

—

Forfeited

​

(1,000,000)

​

​

0.04

​

—

Cancelled

​

(150,000)

​

​

0.01

​

—

Expired

​

—

​

​

—

​

—

Outstanding at September 30, 2021

 

15,722,616

​

$

0.045783

 

8.78

Exercisable at September 30, 2021

​

10,322,616

​

$

0.031274

​

8.63

Schedule of assumptions used in share-based compensation The following assumptions were used to calculate share-based compensation expense for six months ended September 30, 2021:

​

​

​

​

​

Volatility

    

171.12%- 183.48

%

Risk-free interest rate

​

0.46% - 0.86

%

Dividend yield

 

0.0

%

Expected term

 

5.0 – 5.75

years

Schedule of restricted stock awards activity

​

​

​

​

​

​

​

​

​

​

​

Weighted 

​

​

​

​

Average

​

​

Number of

​

Grant Date 

​

    

Units

    

Fair Value

Granted

 

7,311,904

​

$

0.023

Exercised and converted to common shares

​

(5,928,571)

​

​

0.014

Forfeited

​

—

​

​

—

Outstanding at December 31, 2020

​

1,383,333

​

$

0.060

Granted

​

—

​

​

—

Exercised and converted to common shares

 

(1,383,333)

​

 

0.060

Forfeited

 

—

​

 

—

Outstanding at September 30, 2021

 

—

​

$

—

Exercisable at September 30,2021

 

—

​

$

—

Summary of common stock warrants

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted

​

Weighted

​

​

​

​

Average

​

Average

​

​

Number of

​

Exercise

​

Contractual

​

    

Warrants

    

Price

    

Term in Years

Outstanding at December 31, 2019

 

5,250,000

​

$

0.014000

 

2.81

​

​

​

​

​

​

​

​

Granted

 

2,117,500

​

$

0.050720

 

5.00

Exercised

 

—

​

 

—

 

—

Forfeited

 

—

​

 

—

 

—

Cancelled

 

—

​

 

—

 

—

Expired

 

—

​

 

—

 

—

Outstanding at December 31, 2020

 

7,367,500

​

$

0.050720

 

2.54

Granted

 

24,030,667

​

$

0.142320

 

4.88

Exercised

 

—

​

 

—

 

—

Forfeited

 

—

​

 

—

 

—

Cancelled

 

—

​

 

—

 

—

Expired

 

—

​

 

—

 

—

Outstanding at September 30, 2021

 

31,398,167

​

$

0.114686

 

3.79

Exercisable at September 30, 2021

 

31,398,167

​

$

0.114686

 

3.79